Comparison of Letrozole vs. Clomiphene Citrate for Ovulation Induction in Infertility Patients with Polycystic Ovarian Syndrome
DOI:
https://doi.org/10.48047/d86bf044Abstract
Background: In women of reproductive age, polycystic ovary syndrome or PCOS has become the
most frequent cause of anovulatory infertility. Although CC has been used in the past as the firstline treatment for ovulation induction, recent challenges such as antiestrogen city of the drug and
poor response in certain patients have seen use of the like of letrozole an aromatase inhibitor.
Aim: This five-year multicentre study aimed at comparing the effectiveness, safety, and ovulation –
related pregnancy rates between two methods of ovulation induction – letrozole and clomiphene
citrate – in women with PCOS.
Downloads
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
